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Nicholas C. Dang, MD, Veli K. Topkara, MD, Brian T. Kim, BS, Brian J. Lee, BS, Romolo Remoli,
and Yoshifumi Naka, MD, PhD, New York, NYT he presence of malnutrition and cachexia in patientswith congestive heart failure is well documented.1,2Nutritional status also bears a significant influence onwound healing and immune function in surgical patients
in general. Left ventricular assist devices (LVADs) have become
an acceptable mode of bridge to transplantation for patients with
end-stage heart failure. We propose to study the course of nutri-
tional status in patients receiving LVAD support and correlate this
with their clinical outcomes.
Patients and Methods
Ninety-nine patients undergoing LVAD implantation from January
1996 through February 2003 were retrospectively reviewed.
Patients were evaluated according to 4 preoperative nutritional
parameters: serum albumin level, total protein (TP) level, absolute
lymphocyte count (ALC; white cell count  percentage lympho-
cytes), and body mass index (BMI). Each parameter was catego-
rized as low or normal according to our patient population’s value
range: albumin, 3.5 to 5.3 g/dL; TP, 6.0 to 8.5 g/dL; ALC, 0.85 to
4.10  103/mL3; and BMI, 20 to 25 kg/m2. Low and normal
groups were then compared with regard to demographics, device-
related infections, bridge-to-transplantation rate, total hospital and
intensive care unit (ICU) length of stay (LOS), and posttransplan-
tation survival.
Data were represented as frequency distributions and percent-
ages. Values of continuous variables were expressed as means 
standard deviation. Continuous variables were compared with in-
dependent samplest tests, whereas nominal variables were com-
pared with 2 and Fisher exact tests. Parameters at consecutive
time points were compared with repeated-measures analysis of
variance tests. All data were analyzed with SPSS 11.5 software
(SPSS, Inc, Chicago, Ill).
Results
Demographics. Clinical characteristics and outcomes are
shown in Table 1. Patients with low ALCs were older than those
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Nutritional parameter trends on LVAD support. The
mean values of all nutritional parameters were obtained preoper-
atively and then postoperatively at 1, 2, and 3 months and are
shown in Figure 1. By 3 months, mean serum albumin levels
increased to within normal limits, mean TP levels increased (al-
though not significantly), and there was a trend toward decreasing
mean ALC and BMI.
Postoperative infection rates and LOS. Among postoper-
ative device–related infections, patients with low ALCs had a
higher rate of sepsis than those with normal ALCs. There were no
differences in infection rates between subgroups for any of the
other parameters. The overall rates of sepsis and any type of
infection were 14.1% and 50.5%, respectively. Mean total hospital
LOS was equivalent among subgroups, but mean ICU LOS was
significantly longer in patients with low serum albumin and TP
levels than in those with normal values.
Bridge-to-transplantation rate and posttransplantation
survival. The bridge-to-transplantation rate was significantly
lower in patients with low serum albumin and TP levels than in
those with normal values (Table 1). Posttransplantation actuarial
survivals at 1, 3, and 5 years were equivalent among all subgroups.
Discussion
In this study low preoperative serum albumin level, TP level, and
ALC were associated with poor clinical outcomes, including a
higher rate of sepsis, lower bridge-to-transplantation rate, and
longer ICU LOS. In patients with LVAD support, particularly the
elderly, the consequences of poor nutritional status are decreased
immune function, higher infection rates, and impaired wound
healing. Physical conditioning and rehabilitation efforts might also
be compromised, contributing to diminished survival in the acute
recovery period.
The increase in serum albumin levels over time might reflect
amelioration of the chronic inflammatory state with a shift away
from protein catabolism. This is likely augmented by rehabilitation
on LVAD support and increased nutritional intake. The trend
toward a decrease in ALC over time might relate to CD4 T-cell
apoptosis induced by direct contact of the biosynthetic membrane
in certain pulsatile LVADs with elements of the blood circulation.3
This process can generate defects in cellular immunity, placing
patients at even greater risk of infection. The trending decrease in
BMI with LVAD support likely represents loss of edematous fluid
facilitated by enhanced renal flow.
The practice of nutritional assessment in patients with LVAD
support has been examined previously4 and continues to carry
great importance. Nutritionally at-risk patients should be identified
preoperatively and supplemented according to individual caloric
and substrate needs. Nutritional optimization should continue well
into the intermediate postoperative period.
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e4 The Journal of Thoracic and Cardiovascular Surgery ● NovemStudy limitations include those inherent with retrospective analy-
ses. Moreover, with an overall study sample size of only 99 patients
and even fewer numbers within the nutritional parameter subcatego-
ries, the potential for type II error within individual analyses is
appreciable.
In conclusion, malnutrition predisposes to poor clinical out-
comes, although protein status improves with LVAD support.
Efforts should be made to identify patients at risk and provide
nutritional supplementation throughout the perioperative period.
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